Dual Nephroprotective Strategy of Dapagliflozin and Telmisartan in the Management of Diabetic Kidney Disease: A Comprehensive Review
Pharmacological Approaches in Alcohol Use Disorder-Exploring Off-Label an Emerging Treatments in Clinical and Preclinical Evidence
A Focus on Cystic Fibrosis Transmembrane Regulator (CFTR) Genetic Lesions, Phenotype Expressions and Emerging Therapies for Cystic Fibrosis: An UpdateBy Zishan MTMJune 9, 2025 Author informationCitations Corresponding author. Correspondence: Dr. Shaik Karimulla Department of Pharmacy Practice, College of Pharmacy, University of Hafr Al Batin,…
